摘要
重视高血压治疗中的经济学评价,对利用我国有限的卫生资源来遏制高血压对人民群众的危害有着重要的现实意义。药物经济学对于药物治疗的成本和治疗的结果给予同样的关注。因为治疗高血压的费用,不仅涉及药物价格,还包括患者的危险水平,降压疗效和对临床终点事件的影响,以及治疗的依从性和安全性。因此药物经济学更强调整体成本和价-效比。低危病人,若非药价低廉,治疗的价-效比不够理想。而在高危的患者,价-效比越小越经济而不是药费越便宜越好。
Evaluating drug treatment of hypeitension from the point of view of economics has important practical significance. It is important to make best use of our restricted health resources, whilst preventing harm to patients from hypertension. Pharmacoeconomic analysis seeks to take into account both the cost and the effect of drug treatment, because the cost of drug treatment involves not only drug prices, but also the risk level to patients, the effect of lowering blood pressure, the impact of clinical end points and the compliance with treatment and safety of treatment. Pharmacoeconomics places an emphasis on overall costs and cost-effectiveness. Drug treatment is not very cost-effective for low-risk patients, unless drug prices are low. However, for high-risk patients, the lower the cost-effective ratio is the more economic rather than the cheaper drug.
出处
《心血管病学进展》
CAS
2006年第5期550-554,共5页
Advances in Cardiovascular Diseases
关键词
高血压
药物
治疗
经济学
hypertension
drug treatment
economics
